Adam Idoine, PhD
About Adam Idoine, PhD
Adam Idoine, PhD, is a Senior Manager in Clinical Science at BeiGene, with extensive experience in molecular biology and clinical trial development.
Professional Role at BeiGene
Adam Idoine, PhD, serves as a Senior Manager in Clinical Science at BeiGene, based in San Mateo, California. In this role, he plays a crucial part in developing clinical trial protocols and implementing data-driven strategies to optimize clinical trial outcomes. He is actively involved in mentoring junior scientists and researchers, contributing significantly to the success of the company's clinical trials.
Previous Experience at SafeTraces, Inc.
Adam Idoine previously worked at SafeTraces, Inc. in Pleasanton, California. He held the position of Senior Scientist for three months in 2020 and was a Consumables and Process Development Scientist from 2018 to 2020. During his tenure, he contributed to various scientific initiatives and enhanced the company's R&D capabilities.
Postdoctoral Research at Carnegie Institution for Science
From 2014 to 2018, Adam Idoine was a Postdoctoral Researcher in Molecular Biology at the Carnegie Institution for Science in Stanford, California. He was involved in extensive research projects, utilizing advanced molecular biology techniques such as CRISPR and RNA sequencing. His work during this period led to several publications in peer-reviewed scientific journals.
Academic Background and Research Expertise
Adam Idoine holds a PhD in Molecular Biology from the Max Planck Institute of Molecular Plant Physiology, where he studied from 2008 to 2013. He also earned a Bachelor of Science (Honours) in Biochemistry from the University of Otago. His academic background includes contributions to research projects at the University of Otago, the University of Auckland, and Massey University, focusing on molecular ecology and evolutionary biology.
Industry Experience in Molecular Biology
In addition to his academic and clinical roles, Adam Idoine has extensive experience in the molecular biology field. He worked as a Molecular Biology Research Assistant at LanzaTech in Auckland, New Zealand, in 2008, and held a position at GMP Pharmaceuticals Ltd as a Lab Technician from 2004 to 2005. His expertise in molecular biology has been recognized through various publications and presentations at international conferences, including the American Society of Clinical Oncology (ASCO) Annual Meeting.